These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 2866705)

  • 1. Rationale for calcium entry-blocking drugs in systemic hypertension complicated by coronary artery disease.
    O'Rourke RA
    Am J Cardiol; 1985 Dec; 56(16):34H-40H. PubMed ID: 2866705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional coronary vasoconstriction after combined beta-adrenergic and calcium channel blockade in patients with coronary artery disease.
    Kern MJ; Petru MA; Ferry DR; Eilen SD; Barr WK; Porter CB; O'Rourke RA
    J Am Coll Cardiol; 1985 Jun; 5(6):1438-50. PubMed ID: 2860147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of nitrates, nitrate-like substances, calcium antagonists and beta-adrenergic receptor blockers on peripheral circulation].
    Busse R; Bassenge E
    Herz; 1982 Dec; 7(6):388-405. PubMed ID: 6131027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of patients with hypertension and angina pectoris.
    Bush DE; Bulkley BH
    Am J Med; 1984 Aug; 77(2B):28-34. PubMed ID: 6148886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium channel blockers in patients with both hypertension and angina pectoris.
    Frishman WH; Lazar EJ
    J Cardiovasc Pharmacol; 1988; 12 Suppl 6():S69-74. PubMed ID: 2468912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination drug therapy with calcium-channel blockers in the treatment of systemic hypertension.
    Frishman WH; Landau A; Cretkovic A
    J Clin Pharmacol; 1993 Aug; 33(8):752-5. PubMed ID: 8104960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
    Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
    Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium channel blocking drugs for chronic, stable angina.
    O'Rourke RA
    Int J Cardiol; 1982; 2(1):1-5. PubMed ID: 6127320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamic effects of felodipine at rest and during exercise in exertional angina pectoris.
    Detry JM; De Coster PM; Renkin J
    Am J Cardiol; 1983 Sep; 52(5):453-7. PubMed ID: 6613867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive drug management of angina pectoris.
    Pepine CJ; Feldman RL; Conti CR
    Cardiovasc Clin; 1984; 14(3):139-51. PubMed ID: 6144388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE inhibitors, beta-blockers, calcium blockers, and diuretics for the control of systolic hypertension.
    Morgan TO; Anderson AI; MacInnis RJ
    Am J Hypertens; 2001 Mar; 14(3):241-7. PubMed ID: 11281235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The importance of circadian rhythms on drug response in hypertension and coronary heart disease--from mice and man.
    Lemmer B
    Pharmacol Ther; 2006 Sep; 111(3):629-51. PubMed ID: 16480770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
    Simon R
    Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antianginal and antiadrenergic therapy in acute coronary syndrome].
    Raos V; Bergovec M
    Acta Med Croatica; 2004; 58(2):123-7. PubMed ID: 15208797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of calcium entry-blocking drugs, beta-blocking drugs, and their combination in patients with chronic stable angina.
    Kostuk WJ; Pflugfelder P
    Circulation; 1987 Jun; 75(6 Pt 2):V114-21. PubMed ID: 2882870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Choosing the most appropriate treatment for stable angina. Safety considerations.
    Asirvatham S; Sebastian C; Thadani U
    Drug Saf; 1998 Jul; 19(1):23-44. PubMed ID: 9673856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium-channel blockers for combined angina pectoris and systemic hypertension.
    Frishman WH; Charlap S; Kimmel B; Goldberger J; Phillippides G; Klein N
    Am J Cardiol; 1986 Feb; 57(7):22D-29D. PubMed ID: 3513513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium antagonists.
    Conti CR; Pepine CJ; Feldman RL; Hill JA
    Cardiology; 1985; 72(5-6):297-321. PubMed ID: 2866840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is preferable in unstable angina, beta-blockade or calcium-inhibition?
    Hugenholtz PG; Serruys PW; Simoons ML
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():199-209. PubMed ID: 6134510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.